Related Experiment Video
Updated: Dec 9, 2025
Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
How Parkinson's disease-related mutations disrupt the dimerization of WD40 domain in LRRK2: a comparative molecular
Xinyi Li1, Mingyu Ye1, Yue Wang1
1Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University, School of Medicine, Shanghai, 200025, China. lushaoyong@yeah.net.
Abstract:
The multidomain kinase enzyme leucine-rich-repeat kinase 2 (LRRK2), activated through a homodimerization manner, has been identified as an important pathogenic factor in Parkinson's disease (PD), the second most common neurodegenerative disease wordwide. The Trp-Asp-40 (WD40) domain, located in the C-terminal LRRK2, harbours one of the most frequent PD-related variants, G2385R. However, the detailed dynamics of WD40 during LRRK2 dimerization and the underlying mechanism through which the pathogenic mutations disrupt the formation of the WD40 dimer have remained elusive. Here, microsecond-scale molecular dynamics simulations were employed to provide a mechanistic view underlying the WD40 dimerization and unveil the structural basis by which the interface-based mutations G2385R, H2391D and R2394E compromise the corresponding process. The simulation results identified important residues, D2351, R2394, E2395, R2413, and R2443, involved in establishing the complex binding network along the dimerization interface, which was significantly weakened in the presence of interfacial mutations. A "sag-bulge" model was proposed to explain the unfavorable dimer formation in the mutant systems. In addition, mutations altered the community configuration in the wild-type system in which inter-monomeric interplay is prominent, leading to the destabilization of the WD40 dimer under mutation.
Insights
Leucine-rich-repeat kinase 2 (LRRK2) mutations impact Parkinson's disease (PD) pathogenesis. Molecular dynamics simulations reveal how mutations disrupt the WD40 domain dimerization, destabilizing the LRRK2 enzyme crucial for neuronal health.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Leucine-rich-repeat kinase 2 (LRRK2) is a key pathogenic factor in Parkinson's disease (PD).
- The WD40 domain of LRRK2 contains frequent PD-related variants, such as G2385R.
- Mechanisms of LRRK2 WD40 domain dimerization and mutation-induced disruption remain unclear.
Purpose of the Study:
- To elucidate the dynamics of LRRK2 WD40 domain dimerization.
- To uncover the structural basis by which PD-related mutations disrupt WD40 dimerization.
- To provide a mechanistic view of WD40 dimer formation and destabilization.
Main Methods:
- Microsecond-scale molecular dynamics simulations were utilized.
- Analysis focused on the dimerization interface of the LRRK2 WD40 domain.
- Simulations investigated wild-type and mutant systems (G2385R, H2391D, R2394E).
Main Results:
- Identified key residues (D2351, R2394, E2395, R2413, R2443) critical for WD40 dimerization.
- Interfacial mutations significantly weakened the binding network at the dimerization interface.
- A 'sag-bulge' model was proposed to explain unfavorable dimer formation in mutants.
Conclusions:
- LRRK2 WD40 domain dimerization is essential for LRRK2 function.
- PD-associated mutations compromise WD40 dimer stability through disruption of the binding network.
- Mutations alter protein community configuration, leading to WD40 dimer destabilization.
